Search Results for "Virusus Going Around In San Antonio"

05:35 EST 7th December 2016 | BioPortfolio

Matching Channels


Matching News

Biomed Researchers at San Antonio’s UT Health Pitch for $25K Awards

San Antonio — For biotech researchers, even a few thousand dollars in early funding can provide that extra runway that turns a simple (or complex) idea into a startup. At the University of Texas...

Inspyr Leaves San Antonio for California to Be Near Clinical Trials

San Antonio — Inspyr Therapeutics has moved out of San Antonio. The news comes a couple of months after the tumor-fighting biotech hired Chris Lowe to serve as president and CEO. Lowe replaced c...

San Antonio startup obtains $350K in funding round

An offering of convertible notes has pulled in $350,000 for San Antonio-based Cardiovate, an early-stage developer of a polyc -More- 

2016 San Antonio Breast Cancer Symposium to be held Dec. 6-10

(American Association for Cancer Research) The Cancer Therapy & Research Center at The University of Texas Health Science Center at San Antonio, the American Association for Cancer Research, and Baylo...

San Antonio venture capital firm seeks more funding for medtech, biotech

San Antonio-based Fountainhead Investment Partners is raising additional money as it intends to invest in medical device and  -More- 

Nonprofit LifeNet Acquires Biotech With San Antonio Presence

San Antonio — Virginia nonprofit LifeNet Health has acquired the assets of a biotech company that has a top executive based in San Antonio. In acquiring Birmingham, AL-based Vivo Biosciences, L...

After $70M Boston Scientific Deal, CeloNova CEO Heads to Nonprofit

San Antonio — Martin Landon, a long-time San Antonio life sciences executive, has left the chief executive role at medical device maker CeloNova Biosciences a year after selling a portion of the...

MetaStat Announces Presentation of Two MetaSite Breast™ Studies at the 2016 San Antonio Breast Cancer Symposium

Monday, August 29th 2016 at 1:06pm UTC BOSTON–(BUSINESS WIRE)– MetaStat, Inc. (OTCQB:MTST), a molecular diagnostic company, today announced the company will present clinical data and resul...

Matching PubMed Articles

Search Whole site using Google

Quick Search
Advertisement Advertisement